Cost-Effectiveness Analysis of Baricitinib Versus Adalimumab for the Treatment of Moderate-To-Severe Rheumatoid Arthritis in Spain

ClinicoEconomics and Outcomes Research - New Zealand
doi 10.2147/ceor.s201621
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Pms47 - Cost-Effectiveness of Tofacitinib Compared With Adalimumab in the Treatment of Moderate to Severe Rheumatoid Arthritis in Iran

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Mean Cost Per Number Needed to Treat of Baricitinib Versus Adalimumab in the Treatment of Rheumatoid Arthritis in Italy

Global and Regional Health Technology Assessment
Health Policy
2018English

Cost-Effectiveness of Adalimumab for Rheumatoid Arthritis in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Pms41 - Cost-Effectiveness Analysis of Tofacitinib in Combination With Methotrexate in the Treatment of Moderate to Severe Rheumatoid Arthritis in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pmu66 - Cost-Effectiveness Analysis of Ixekizumab Versus Secukinumab in Patients With Psoriatic Arthritis and Concomitant Moderate-To-Severe Psoriasis in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Reply To: Need for Improvements in Reported Cost-Effectiveness of Adalimumab in Rheumatoid Arthritis

Zeitschrift fur Rheumatologie
Rheumatology
2017English

PMS30 Cost-Effectiveness of Tocilizumab Compared to Standard Therapeutic Sequences for the Treatment of Moderate/Severe Rheumatoid Arthritis (RA) Patients in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Total Knee Arthroplasty Treatment of Rheumatoid Arthritis With Severe Versus Moderate Flexion Contracture

Journal of Orthopaedic Surgery and Research
SurgeryOrthopedicsSports Medicine
2013English

Pms1 - Comparative Effectiveness of Baricitinib Versus Sarilumab in Rheumatoid Arthritis: A Systematic Review and Network Meta-Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy